We have previously shown that TDP-43 overexpression can enhance microglial toxicity toward neighboring neurons via NF-κB pathway and that NF-κB inhibition by Withaferin A treatment of TDP-43 mouse model reduces ALS disease symptoms [14]. Here, NFKB1 is linked to amyotrophic lateral sclerosis.